| Joseph Heinrick Marceny, MD | |
|
6065 S Quebec St, Ste 100, Englewood, CO 80111 | |
| (303) 694-2323 | |
| (303) 694-9191 |
| Full Name | Joseph Heinrick Marceny |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 6065 S Quebec St, Englewood, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205890480 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 36109 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Heinrick Marceny, MD 6065 S Quebec St, Ste 100, Englewood, CO 80111 Ph: (303) 694-2323 | Joseph Heinrick Marceny, MD 6065 S Quebec St, Ste 100, Englewood, CO 80111 Ph: (303) 694-2323 |
News Archive
A new study published on the preprint server bioRxiv* in August 2020 shows that the man-made compound silicon nitride, which is used in medical implants and high mechanical performance engineering applications, is capable of inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at varying concentrations without causing cell cytotoxicity. This finding should be investigated to develop disinfectants to clear the virus from surfaces, preventing its spread.
The preliminary results of a malaria vaccine trial in African infants show that the vaccine gave a high level of protection and was also safe.
A New Year's resolution to get in shape is good news for your health. But if you have allergies or asthma, the hidden triggers at the gym may be bad for your condition.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, noted today that individual site, investigator-initiated results of an ongoing Phase 3 clinical trial of 99m-Tc-Tilmanocept (Lymphoseek) were presented at the American Head and Neck Society's 8th International Conference on Head and Neck Cancer (ICHNC), held in Toronto, July 21-25, 2012.
Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.
› Verified 1 days ago
Adam Layne Huff, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6065 S Quebec St, Ste 100, Englewood, CO 80111 Phone: 303-694-2323 Fax: 303-694-9191 | |
Dr. Michele M Chetham, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 180 E Hampden Ave, Englewood, CO 80113 Phone: 303-789-4968 Fax: 303-789-6018 | |
Dr. Edward B Arenson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 499 E Hampden Ave, Ste 450, Englewood, CO 80113 Phone: 720-389-7749 Fax: 720-519-0229 | |
E. A. Kastendieck, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2955 S Broadway, Englewood, CO 80113 Phone: 303-788-1052 | |
Edward R. Berman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 70 Charlou Cir, Englewood, CO 80111 Phone: 303-740-8080 Fax: 303-740-9328 | |
Carlos Barajas, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 501 E Hampden Ave, Englewood, CO 80113 Phone: 303-788-7428 |